Use access key #2 to skip to page content.
$19.30 1.43 (8.00%)
10/10/2008 4:00 PM

Somanetics Corp (SMTS)

CAPS Rating:
*****

Develops, manufactures and markets the INVOS Cerebral Oximeter, the only non-invasive patient monitoring system commercially available in the United States that continuously measures changes in the blood oxygen level in the adult brain.

View Ticker Page (SMTS)

Results 1 - 10 of 25 :   123

Recs

2

Avatar vanonuma (55.66) Submitted: 4/23/08 4:17 AM : Outperform Start Price: $15.70 SMTS Score: 58.68

This is the Netflix of Oxygen monitoring. Not too sophisticated, one really convenient product, easy to sell and easy for hospitals to buy. Patients don't get jabbed-- Heck, maybe I will just get started monitoring myself now...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar foolazis (41.87) Submitted: 9/01/06 12:31 AM : Outperform Start Price: $16.89 SMTS Score: 46.64

Large, untapped potential market. No debt and excellent earnings growth.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar phil155 (92.64) Submitted: 8/24/06 1:55 AM : Outperform Start Price: $16.75 SMTS Score: 47.19

I picked this based on quarterly growth and PEG ratio. Does this qualify as a boring stock in the medical technology field?

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar toxfinan (27.36) Submitted: 12/12/07 12:58 PM : Outperform Start Price: $21.91 SMTS Score: 28.77

This company should be bought by Johnson andJohnson

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar mill2bill (71.90) Submitted: 3/05/08 10:53 PM : Outperform Start Price: $27.29 SMTS Score: 4.17

great company. Stock gets ahead of itself every once in a while, but eanrings growth has been consistent.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar GunnarVagotis (84.65) Submitted: 3/18/08 3:31 PM : Outperform Start Price: $13.16 SMTS Score: 79.81

Overreactions seem particularly extreme these days. Maybe because the financial world is about to collapse? Maybe. I am guessing a 20% bounceback is conceivable if there is no new bad news.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar tomk0508 (97.94) Submitted: 5/11/08 6:51 PM : Outperform Start Price: $16.73 SMTS Score: 51.81

Great business model solid margins nothing but growth ahead.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar ninjin274 (< 20) Submitted: 5/12/08 3:59 AM : Outperform Start Price: $16.73 SMTS Score: 51.81

Will touch $28 in few months

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar stoxmri (< 20) Submitted: 6/05/08 12:16 AM : Outperform Start Price: $16.98 SMTS Score: 49.88

The company has put a floor under the stock at 15 by doubling the stock buyback pool after telling investors they paid around 15 in the open market in April. They are going to have a positive earnings surprise on June 18 when 2Q will be reported and ...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar nacjr (< 20) Submitted: 6/24/08 8:32 AM : Outperform Start Price: $17.35 SMTS Score: 46.64

Given that the company has, still, some available cash left to continue (re) purchasing some of its stock, if they continue on this trail, I believe that the market will reward them.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners